Prothena | PRTA - Ordinary Share Capital

Stock Price
8.73
Daily Change
-0.18 -2.02%
Monthly
-4.07%
Yearly
-39.75%
Q1 Forecast
8.55

Prothena reported $53.83M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 168.71M 104K Sep/2025
Agios Pharmaceuticals USD 58.28M 241K Sep/2025
ALKERMES USD 165.1M 49K Sep/2025
Alnylam Pharmaceuticals USD 131.79M 130.49M Sep/2025
Amgen USD 538M 300K Sep/2025
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 192.1M 97K Sep/2025
Exelixis USD 268.1M 2.03M Sep/2025
Incyte USD 196.13M 2.01M Sep/2025
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
MacroGenics USD 63.26M 62.63M Sep/2025
Neurocrine Biosciences USD 99.7M 700K Sep/2025
Prothena USD 53.83M 53.29M Sep/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
Vertex Pharmaceuticals USD 254M 2.29M Sep/2025